Malik Kemal (CIK 1797921) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-06). Recent activity: Buy RNAC (2,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-06 | Cartesian Therapeutics, Inc. (RNAC) | Director | Buy | 2,600 | $0 |
Source: SEC Form 4 filings · as of 2026-01-06